Figure 2: Alanine scanning mutagenesis of AcrF1.

The side chains of substituted surface-exposed residues are indicated. Substitution of the side chains shown in grey had a 10-fold or less effect on in vivo anti-CRISPR activity. Substitution of the three residues shown in blue resulted in a 100-fold or greater decrease in in vivo activity.